Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech announces colorectal cancer phase 2 study in female patients

June 29 (Reuters) - Oncolytics Biotech Inc  ONC.TO  
    * Oncolytics biotech inc. announces phase 2 study in female 
patients with colorectal cancer metastatic to the liver 
 
Source text for Eikon:  ID:nPn1DL1Jla  
Further company coverage:  ONC.TO

Recent news on Oncolytics Biotech

See all news